U.S. Markets closed
  • S&P Futures

    4,268.50
    -8.25 (-0.19%)
     
  • Dow Futures

    33,919.00
    -44.00 (-0.13%)
     
  • Nasdaq Futures

    13,454.75
    -38.50 (-0.29%)
     
  • Russell 2000 Futures

    1,986.90
    -2.20 (-0.11%)
     
  • Crude Oil

    87.73
    -0.38 (-0.43%)
     
  • Gold

    1,779.20
    +2.50 (+0.14%)
     
  • Silver

    19.75
    +0.02 (+0.10%)
     
  • EUR/USD

    1.0185
    +0.0005 (+0.0509%)
     
  • 10-Yr Bond

    2.8930
    +0.0690 (+2.44%)
     
  • Vix

    19.90
    +0.21 (+1.07%)
     
  • GBP/USD

    1.2049
    -0.0002 (-0.0169%)
     
  • USD/JPY

    134.9220
    -0.1680 (-0.1244%)
     
  • BTC-USD

    23,346.05
    -525.75 (-2.20%)
     
  • CMC Crypto 200

    554.73
    -18.08 (-3.16%)
     
  • FTSE 100

    7,515.75
    -20.31 (-0.27%)
     
  • Nikkei 225

    29,222.77
    0.00 (0.00%)
     

SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
SeaSpine Holdings Corporation
SeaSpine Holdings Corporation

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.

A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: www.seaspine.com.

About SeaSpine

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.


Investor Relations Contact
Leigh Salvo
ir@seaspine.com